Concurrently, an analysis predicated on two markers of T-cell activation, CD69 and CD25, revealed a substantial augmentation in the proportion of activated CD8 T cells within the tumor, along with a notable escalation in the concentration of cytokines in the interstitial fluid of the tumor. The gene discussed is CD69; the disease is neoplasm.